Serimat - Serigen Mediproducts Private Limited

Products

SERIMAT

Superior Soft Tissue Regeneration

Serimat is a silk protein-based matrix engineered to promote soft tissue regeneration. Its unique design ensures appropriate surface texture, suitable pore size and porosity, and excellent mechanical properties. Moreover, Serimat is suturable and conformable, making it an ideal soft tissue regeneration matrix in implant-based breast reconstruction surgery and other clinical applications.

Serimat has proven biocompatibility and outperforms leading global products in soft tissue and blood vessel formation. In lab and large animal (pig model) studies, Serimat was well tolerated at implantation sites.

Unmet Need

Serimat addressed the unmet need for an affordable synthetic soft tissue regeneration matrix that can support organ reconstruction surgeries and minimise surgical complications.

Applications of Serimat

With its unique properties and novel silk protein-based design, Serimat is potentially suitable for the following applications –

USPs of Serimat

Ideal Mechanical Properties

Serimat has an appropriate surface texture, suitable pore size and porosity, and excellent mechanical properties. It is suturable and conformable, making it ideal for clinical applications.

Bio-compatibility

Serimat has proven bio-compatibility and outperforms leading global products in soft tissue and blood vessel formation. In lab and large animal (pig model) studies, Serimat was well tolerated at implantation sites.

Safety

Serimat is non-cytotoxic, non-immunogenic, non-sensitizing, non-irritant and does not induce systemic toxicity. It meets ISO 10993 standards for safety certified by Intox Pvt. Ltd. (Pune, IN)

Diverse Applications

Serimat is available in different sizes to suit diverse clinical needs. Moreover, the platform technology is suitable for diverse applications in the field of soft tissue regeneration, such as breast reconstruction, vaginal reconstruction, dural repair, and abdominal wall reconstruction.

Product Gallery

Serimat Soft Tissue Regeneration Matrix with Silk Protein

Serimat Tissue Regeneration Matrix with Silk

Serimat Soft Tissue Regeneration Matrix for Breast Implants

Serimat Tissue Regeneration With Silk

Serimat Serigen Mediproducts

Ravi Sarangpani

Consultant – Medical Devices

Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.

Consultant, Medical Devices

Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.

Adler Mediequip, A Smith & Nephew Company. Director NPD
2014 – 2019

Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.

Adler Mediequip. VP – Development & Quality Management
2010 – 2014

Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.

Sushrut Surgicals – A Sushrut-Adler Group Company
2001 – 2010 VP Marketing and Sales
1993 – 2000 Marketing Manager

Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.